Tinea Pedis Treatment Market

Future Market Insights

Key Insight

Tinea pedis treatment sales will expand through 2035, with interdigital tinea pedis at 47.6% within the disease indication segment and topical treatments at 71.0% of the administration category in 2025. The market was valued at USD 1.6 billion in 2025 and is forecast to record a 5.2% CAGR between 2025 and 2035.

October 23, 2025

Anurag Sharma

250 Pages

Cite this Report

Tinea Pedis Treatment Market

https://www.futuremarketinsights.com/reports/tinea-pedis-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

Blueberry Therapeutics Ltd
Glenmark Pharmaceuticals
McKesson (NorthStar Rx LLC)

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Tinea Pedis Treatment Market

Key Players

Similar Industry Reports